Risk factors for early work disability in systemic lupus erythematosus. Results from a Multicenter Study
✍ Scribed by Alison J. Partridge; Anne H. Fossel; Elizabeth W. Karlson; Robert A. Lew; Elizabeth A. Wright; Lawren H. Daltroy; Matthew H. Liang; Karin V. Straaton; Steven H. Stern; Arthur F. Kavanaugh; W. Neal Roberts
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 760 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective Patients with systemic lupus erythematosus (SLE) are significantly more likely to experience a myocardial infarction or a stroke than age‐matched controls. We compared the prevalence of conventional and lupus‐specific risk factors in patients with SLE just before a cardiov
## Abstract ## Objective To determine whether LJP 394 delays or prevents renal flare in patients with systemic lupus erythematosus (SLE) and a history of renal disease. ## Methods In a 76‐week, double‐blind, placebo‐controlled study, 230 SLE patients were randomized to receive 16 weekly doses of
## Abstract ## Objective To clarify whether age at the time of the initial administration of corticosteroids is a risk factor for corticosteroid‐associated osteonecrosis in children with systemic lupus erythematosus (SLE), using magnetic resonance imaging (MRI). ## Methods From 1986 to 2007, MRI
## Abstract ## Objective Venous thrombosis is a relatively frequent and serious complication in systemic lupus erythematosus (SLE) that has been associated with the presence of antiphospholipid antibodies (aPL). However, venous thrombotic events can also be seen in patients without aPL, and only a